Ozempic, a Novo Nordisk diabetes drug, may reduce the risk of opioid overdose, study finds
Recent research suggests that Ozempic, a diabetes treatment developed by Novo Nordisk, may play an unexpected role in reducing the risk of opioid overdose. The finding introduces a potentially game-changing…
